About 15 to 25% of patients suffering from diabetes mellitus tend to develop diabetic foot ulcer during their lifetime.
Skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. These substitutes are used to replace damaged or missing skin in patients and can be utilized in a variety of medical fields, including plastic surgery, dermatology, and burn care. Additionally, key developments in the field of skin substitutes such as the use of advanced materials, such as nanofibers and hydrogels, and the development of new manufacturing techniques that allow for the creation of products that are more consistent and reliable. These advances are likely to lead to the creation of products that are more effective in treating a wider range of skin injuries. This in turn is expected to create lucrative opportunities for the growth of global skin substitutes market in the coming years.
Advantages Associated with Skin Substitutes
One of the major advantages of skin substitutes is their ability to promote wound healing and prevent infection. Skin substitutes are able to create a protective barrier over the wound, preventing further damage and allowing the body to focus on healing. They also provide a framework for new skin cells to grow and can help reduce scarring. Another advantage of skin substitutes is their versatility. Skin substitutes can be used in a variety of medical fields and can be customized to meet the needs of each patient. They can be used to treat a variety of skin injuries, from small cuts and scrapes to large burn injuries. Additionally, skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. They can be used in a variety of medical fields and can be customized to meet the needs of each patient. The development of skin substitutes has revolutionized the treatment of skin injuries and has significantly improved patient outcomes. All these advantages associated with skin substitutes are expected to drive the growth of global skin substitutes market in the coming years.
Use of Stem Cells in the Skin Substitutes
The field of skin substitutes has seen several key developments in recent years, as researchers and medical professionals seek to improve the effectiveness of these products in treating a range of skin injuries. These developments are aimed at creating new products that are more effective, more versatile, and easier to use, and are likely to play an important role in the future of the field. One key development in the field of skin substitutes has been the use of stem cells. Stem cells are cells that have the ability to develop into many different types of cells in the body and have the potential to help regenerate damaged or missing tissue.
Use of 3D Printing in the Skin Substitutes
Growing Popularity of Personalized Medicine
In 2010 there were 36 medicines found at, but in 2020 there were already 286 medicines found at.
Download Free Sample Report
Market Segmentation
Around 3,500 people get fatally injured in a fire or burn accident every year in the United States requiring the use of skin substitutes for treatment purposes, thereby driving the growth of global skin substitutes market.
Market Players
Amarantus BioScience Holdings, Inc., Organogenesis, Inc, Acelity L.P., Inc., Smith & Nephew plc, BSN Medical GmbH, Molnlycke Health Care AB, Integra LifeSciences Corporation, Medtronic Plc, Tissue Regenix Ltd., Stratatech Corporation
- In November 2022, AVITA Medical, Inc.announced that U.S. Food and Drug Administration (FDA) has granted thecompany’s autologous cellular therapy device for skin restoration, RECELLSYSTEM, a designation of breakthrough device. This breakthrough status willhelp in increasing access of RECELL SYSTEM to both patients and healthcareproviders.
- In August 2022, Organogenesis, Inc. announcedthat it has received U.S. Food and Drug Administration (FDA) 510k Clearance forPuraPly MZ. PuraPly MZ is based on the companies PuraPly technology engineeredinto a micronized (powdered) form to provide surgeons with an option forcomplex surgical wounds.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | By Type By Application By End User By Region |
Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
Key companies profiled | Amarantus BioScience Holdings, Inc., Organogenesis, Inc, Acelity L.P., Inc., Smith & Nephew plc, BSN Medical GmbH, Molnlycke Health Care AB, Integra LifeSciences Corporation, Medtronic Plc, Tissue Regenix Ltd., Stratatech Corporation |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |